NCT07167069View on ClinicalTrials.gov

India HIV-CervCa Project

Active, not recruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

February 9, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
HIV PositiveHIV NegativeCervical Cancer
Interventions
RADIATION

Radiation Therapy

Standard of Care Chemoradiation for Cervical cancer patients in India.

Trial Locations (1)

400012

Tata Memorial Hospital, Mumbai

All Listed Sponsors
collaborator

Tata Memorial Hospital

OTHER_GOV

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER